Lungenklinik Hemer

Running trials

• Recruiting

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Source

• Recruiting

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· Phase 3· Source

• Recruiting

  BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation

  NCT05717192· Source

• Recruiting

  An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  NCT06035120· Source

• Active, not recruiting

  Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

  NCT05689671· Phase 4· Source

• Recruiting

  TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

  NCT05538806· Source

• Recruiting

  Post-Market BTVA Registry

  NCT03318406· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD3 recruiting
• Lung cancer3 recruiting
• Mesothelioma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Source

• Completed

  Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

  NCT05054725· Phase 2· Source

• Completed

  Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

  NCT04462276· Phase 2· Source

• Completed

  BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer

  NCT03083691· Phase 2· Source